Healthcare Dive2d
A new, non-opioid pain drug is here. Getting it to patients could be agony.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
BioSpace6d
FDA Approval of Vertex’s Non-Opioid Journavx Signals New Era in Pain Treatment
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
FiercePharma2d
Vertex lays out plan to increase access and launch non-opioid pain reliever Journavx
For Vertex these days ... the company’s fifth cystic fibrosis treatment Alyftrek and its non-opioid pain relief medication Journavx, which was approved to much fanfare by the FDA two weeks ...
The FDA just approved a new painkiller. Is it too good to be true?
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
Vertex Forecasts Upbeat 2025 Revenue on Cystic Fibrosis Treatments Demand
Vertex sees 2025 revenue of $11.75 billion to $12.0 billion, the midpoint of which is above analysts' average expectation of ...
Salon3d
The FDA just approved a new painkiller. Is it too good to be true?
This time around, the media is making a fuss about Vertex Pharmaceuticals ... to rescue medications (probably opioids); we don’t yet have data on how suzetrigine stacks up against non-steroidal ...
Vertex: Strong Sales, Stronger Pipeline
One of the most significant news items involving Vertex isn't reflected in the company's numbers just yet. Vertex's non-opioid pain relief drug, Journavx, received FDA approval on Jan. 30. The drug is ...
The Chemical Engineer6d
FDA approves ‘first’ of new class of non-addictive drugs for severe pain
The US Food and Drug Administration (FDA) has approved a non-opioid drug for severe post-surgical pain, which could “redefine ...
STAT3d
Vertex pain pill dominates earnings call discussion
From my colleague Adam Feuerstein: If you’re curious (and I was) Vertex ... the use of opioids — will convince hospitals, surgeons, and insurers to prescribe the new pain treatment, despite ...